OXA 50mg Injection

About OXA 50mg Injection

Oxa 50mg Injection contains Oxaliplatin, a platinum-based chemotherapy medication used in the treatment of stage III colon cancer following surgical removal of the primary tumor, as well as advanced or metastatic colorectal cancer that has spread to other parts of the body. It is typically administered in combination with other anticancer medications to improve treatment effectiveness. Oxaliplatin works by damaging the DNA of cancer cells, preventing their growth and multiplication, and is particularly effective against certain tumors that may be resistant to cisplatin-based therapies. Colorectal cancer develops in the colon or rectum due to a combination of genetic and environmental factors that lead to abnormal cell growth. Common side effects of Oxa 50mg Injection may include low blood cell counts, nausea, vomiting, diarrhea, indigestion, heartburn, throat discomfort, blood clots, blood in the urine, high blood pressure, insomnia, depression, and low calcium levels. Patients should inform their healthcare provider if these side effects persist or become severe. Before starting treatment, it is important to disclose any history of kidney disease, liver disorders, heart conditions, allergies to Oxaliplatin, or current medications, including vaccinations. Oxa 50mg Injection is generally not recommended during pregnancy or breastfeeding due to the potential risk of harm to the baby. Regular medical monitoring during treatment helps ensure safety and optimize therapeutic outcomes.

Effective Anti-Cancer Solution

OXA 50mg Injection is designed to target colon and rectal cancer directly, offering patients a scientifically advanced treatment option. Its active component, Oxaliplatin, is known for its efficacy in chemotherapy regimens when used in accordance with medical advice. The medicine is delivered as a single injection per box, ensuring precise dosage and ease of administration.


Safe Packaging and Longevity

Each OXA 50mg Injection comes securely packaged for reliable transport and storage. With a long shelf life extending to 2028, patients and healthcare institutions benefit from flexibility in stock management. The product's storage recommendation-below 30C-guarantees optimal stability and potency until use.